0000899243-19-005280.txt : 20190228
0000899243-19-005280.hdr.sgml : 20190228
20190228173626
ACCESSION NUMBER: 0000899243-19-005280
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190227
FILED AS OF DATE: 20190228
DATE AS OF CHANGE: 20190228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schor Chen
CENTRAL INDEX KEY: 0001340875
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38359
FILM NUMBER: 19645233
MAIL ADDRESS:
STREET 1: PREDIX PHARMACEUTICALS HOLDINGS, INC.
STREET 2: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: resTORbio, Inc.
CENTRAL INDEX KEY: 0001720580
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813305277
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-482-2333
MAIL ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-27
0
0001720580
resTORbio, Inc.
TORC
0001340875
Schor Chen
C/O RESTORBIO, INC.
500 BOYLSTON STREET, 12TH FLOOR
BOSTON
MA
02116
1
1
0
0
President and CEO
Stock Option (Right to Buy)
8.53
2019-02-27
4
A
0
214000
0.00
A
2029-02-26
Common Stock
214000
214000
D
25% of the shares shall vest on February 27, 2020, with the remainder vesting in 12 equal quarterly installments thereafter.
/s/ Chen Schor
2019-02-28